DNA Script expands access to DNA synthesis platform in India
DNA Script has announced a distribution agreement with Imperial Life Sciences (ILS) to expand access to the company’s DNA synthesis platform. The partnership will mean DNA Script’s SYNTAX platform will now be available in India. Under the agreement, ILS will distribute DNA Script’s SYNTAX platform throughout the country,… Read More
